Загрузка...
Utilizing T(H)9 cells as a novel therapeutic strategy for malignancies
T(H)9 cells join the ever-growing list of CD4(+) T helper subsets and primarily mediate anti-parasite immune responses. We have recently demonstrated that tumor-specific T(H)9 cells induce a CCL20-CCR6-dependent regulation of DCs while stimulating CD8(+) T cell-mediated antitumor immunity. These fin...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3661147/ https://ncbi.nlm.nih.gov/pubmed/23802062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.23084 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|